The Hellenic Association of Pharmaceutical Companies (SFEE) participated for the 6th consecutive year, on May 10, 2021, in the Delphi Economic Forum, held under the auspices of the President of the Hellenic Republic, M Katerina Sakellaropoulou, at Zappeion Megaron, where emphasis was placed on the importance pharmaceutical production and innovation holds, for the growth of Greek economy and the creation of well-paid jobs.
In particular, Greek Minister for Development and Investment, Adonis Georgiadis, said that the pursuit of the Greek government is the consolidation of a stable investment environment for the pharmaceutical companies to be able to invest.
He went on to state that, regarding investment clawback, the government wants to proceed to a more stable, three-year agreement with the pharmaceutical industry and the Recovery Fund, in order for a stable professional environment for pharmaceutical companies to be established in Greece, stressing that the investment clawback does not constitute a tax exemption and should therefore not raise an issue of state subsidies.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze